Mebeverine Hydrochloride Ibs Aspire Pharma (Malta)

Mebeverine Hydrochloride, the active ingredient in Mebeverine Hydrochloride Ibs Aspire Pharma, is an antispasmodic (smooth muscle relaxant) presented as an oral dosage form for oral use. It is employed to relieve abdominal cramping and irregular bowel habits associated with functional gastrointestinal disorders.

GNH USA supplies Mebeverine Hydrochloride Ibs Aspire Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mebeverine Hydrochloride acts on the smooth muscle of the gastrointestinal tract to alleviate spasm‑related conditions.

- Irritable bowel syndrome: reduces abdominal pain and irregular bowel movements. - Functional gastrointestinal disorders: eases cramping and improves bowel regularity. - Spastic colon: diminishes muscle tone to relieve discomfort.

Mebeverine Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild, transient upset stomach. - Headache: occasional dull or throbbing pain. - Dizziness: brief episodes of light‑headedness. - Dry mouth: reduced salivation. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Palpitations: irregular or rapid heartbeats. - Severe abdominal pain: persistent or worsening discomfort. - Hepatic dysfunction: abnormal liver enzymes. - Blood dyscrasias: unexplained bruising or bleeding.

Before initiating therapy, consider the following safety measures.

- Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Liver impairment: use with caution; monitor hepatic function. - Renal impairment: dose adjustment may be required. - Concomitant medications: review all current drugs for possible interactions. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Mebeverine Hydrochloride can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - CYP3A4 inhibitors: may increase plasma concentrations of mebeverine. - Anticholinergic agents: additive antispasmodic effects could exacerbate constipation.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, TCAs): monitor for enhanced gastrointestinal side effects. - Antihistamines: may increase sedation or dizziness. - Other smooth‑muscle relaxants: assess cumulative effect on gut motility.